National Centre for Cell Science

Scientific Program Schedule

Click Here for the detail Program

Scientific Themes

	Tumor Heterogeneity & Microenvironment Explores how genetic, epigenetic, and phenotypic diversity within tumors influences progression and therapy resistance. Focuses on interactions between cancer cells, stroma, and immune components, and how the microenvironment dynamically shapes tumor evolution, opening avenues for microenvironment-targeted therapies.
	Cancer Cell Signaling & Metastasis Addresses dysregulated signaling pathways that drive tumor growth, invasion, and dissemination. Highlights molecular mechanisms underlying metastasis and therapeutic resistance. Emphasis on integrative research combining signaling biology with novel anti-metastatic interventions to improve outcomes in advanced cancers.
	Cancer Immunology & Vaccines Covers immune evasion strategies of tumors, development of therapeutic and preventive cancer vaccines, and novel immunotherapies. Focuses on advances in immuno-oncology, checkpoint inhibition, and combinatorial approaches that strengthen immune surveillance and enhance durable cancer control.
	Cancer Omics Showcases large-scale omics approaches that decode tumor biology and reveal biomarkers for precision oncology. Highlights proteogenomics linking genetic mutations with functional protein changes, providing deeper insights into tumor networks and therapeutic vulnerabilities.
	Cancer Metabolism & Therapy Examines metabolic reprogramming in cancer cells and therapeutic opportunities arising from metabolic vulnerabilities. Discusses novel drugs, small molecules, and combinatorial therapies targeting altered metabolism, aiming to overcome resistance and enhance treatment efficacy.

Speakers

Dr. Lawrence Banks Director-General – ICGEB,Trieste, Italy Research area:Molecular virology of human papillomaviruses and their role in cancer.	Dr. Patrick Soon-Shiong Executive Chairman and Global Chief Medical & Technology Officer at ImmunityBio, Inc. Chairman and Chief Executive Officer of NantWorks, LLC	Dr. Elizabeth R. Unger Chief of the Chronic Viral Disease Branch (CVDB), Centers for Disease Control and Prevention (CDC), Atlanta, Georgia. USA.	Prof. Kumaravel Somasundaram Professor, Department of Microbiology and Cell Biology, IISc Bengaluru, India Research area:Molecular pathogenesis and therapeutic targets in glioblastoma.
Dr. Sagar Sengupta Director,BRIC-NIBMG, Kalyani, West Bengal, India Research area: Genome integrity, tumor suppressors, and oncogenic signaling	Dr. Anup Tamhankar Surgical Oncologist, DMHRC Pune, India Research area: Gastrointestinal cancers, peritoneal malignancies, HIPEC, and robotic oncologic surgery.	Dr. Brijesh Kumar Assistant Professor, School of Biomedical Engineering, IIT Research area: Cancer Biology, Cell Engineering and Therapeutics	Dr. Dimple Notani Associate Professor, National Centre for Biological Sciences – TIFR (NCBS–TIFR), Bengaluru, India. Research area: Functional enhancers and 3D genome organisation in transcriptional regulation during development and disease.
Dr. Girdhari Lal Scientist – F, BRIC-NCCS, Pune, India Research area: Cancer immunology, Neuro‐immune communication, immune tolerance and autoimmunity	Dr. Murali Dharan Bashyam Staff Scientist VII, BRIC-CDFD, Hyderabad, India Research area: Chromatin remodeling and genetic alterations in Indian cancers.	Dr. Prasanna Venkatraman Deputy Director - CRI ACTREC, Navi Mumbai, India Research area: Protein-protein interactions and signaling networks in cancer.	Dr. Prashant Kumar Datar Cancer Genetics Research area: Proteogenomics and Cancer Biology
Dr. Ramesh Ummani Sr. Principal Scientist, CSIR – IICT, Hyderabad, India Research area:Cancer epigenetics and biomarker discovery.	Dr. Ritu Gupta Professor, AIIMS – New Delhi, India Research area: Hemato-oncopathology and cancer genomics	Prof. Samit Chattopadhyay Senior Professor, BITS Pilani, K. K. Birla Goa Campus Research area: Epigenetics, Gene regulation in metastatic cancers and proliferative immune cells, chromatin remodeling	Dr. Sanjeev Das Staff Scientist-VII, BRIC – NII, New Delhi, India Research area: Regulation of tumor suppressor pathways and metabolic regulation.
Dr. Sanjiban Chakrabarty Associate Professor, Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education (MAHE) Research area: Molecular mechanisms of carcinogenesis, chemotherapeutic resistance	Dr. Santosh Kumar Sandur Scientist, Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre (BARC), Mumbai Research area: Redox signaling, and mechanisms of oxidative stress in cancer and inflammation.	Dr. Shilpa Gadgil Vice-President, Head of Process & Analytical Development and Head of CDMO Development, Enzene Biosciences Ltd., Pune. Research area: Biologics and biosimilars development, process optimization, and analytical innovation in biopharma.	Dr. Sharmila Bapat Director (Additional Charge), BRIC – NCCS, Pune, India Research area: Tumor heterogeneity, ovarian cancer stem cells, and epigenetic regulation.
Dr. Soumen Chakraborty Scientist-F, BRIC-ILS BBSR, Bhubaneswar, India Research area:Leukemia stem cell biology and disease mechanisms.	Dr. Soumen Manna Biophysics & Structural Genomics Division, Saha Institute of Nuclear Physics, Kolkata Research area: Structural biology, protein–nucleic acid interactions, and molecular mechanisms of transcription regulation.	Dr. Somsubhra Nath Assistant Professor, Presidency University Research area: Cancer Biology	Dr. Sorab Dalal Principal Investigator, ACTREC, Navi Mumbai, India Research area:Desmosome regulation and therapy resistance in cancer.
Dr. Sujit Kumar Bhutia Professor, Department of Life Sciences, National Institute of Technology Rourkela (NIT Rourkela), Odisha Research area: Autophagy, apoptosis, and cancer cell biology .	Dr. Sukesh Bhaumik Professor, SIU School of Medicine, Illinois, USA Research area:Chromatin structure and transcription regulation in cancer	Dr. Uttiya Basu Professor, Columbia University New York, USA Research area: RNA surveillance, noncoding RNA processing and DNA alteration events in lymphocytes	Dr. Virendra Gajbhiye Scientist E, Agharkar Research Institute (Centre for Nanobioscience), Pune Research area: Nanomedicine and targeted drug/siRNA delivery for cancer therapy.
Dr. Vivek Tanavde Associate Professor,Ahmedabad University Research area: Adult Stem Cells, miRNA Regulation of Cell Differentiation, Cancer Biomarkers

DETAIL PROGRAM

Click Here for the details program

IC3R-2025 brings together leading experts across cancer biology, translational research, and patient advocacy to share cutting-edge insights and foster collaborations. The scientific program has been designed to reflect diverse themes and research areas, ensuring opportunities for meaningful dialogue across disciplines. We invite all participants to actively engage in sessions, interact with speakers, and contribute to shaping discussions that will drive innovation in cancer research and care.
For program-related queries or updates, please reach out to the organizers at ic3r.nccs@gmail.com.